The Columbia lecture was originally scheduled as a debate between David Healy, MD and James Coyne, PhD. The debate did not take place, and Dr. Coyne subsequently lectured in Rutgers the following week. The lecture covered the main points Dr. Coyne makes in the e-mail below. Dr. Healy’s response follows….
Loss of Trust: Big Drug Makers See Sales Decline With Their Image – NYT Mon, 14 Nov 2005 The lead front page article in today’s New York Times reports: “A poll last month showed that only 9 percent of Americans believed drug companies were generally honest, down from 14 percent…
Dr. Scott Gottlieb’s ties to drug firms spark questions over agency hiring policies
"Every year, drug companies spend $14 billion to test experimental substances on humans. Across the U.S., the centers that do the testing–and the regulators who watch them–allow scores of human test subjects to be injured or killed."
Former FDA Commissioner or Wife Held Stock in FDA Regulated Area – NYT Thu, 27 Oct 2005 The mystery behind the resignation of Dr. Lester Crawford seems to be about failure to divest from financail holdings in companies regualted by the FDA. The New York Times cites Dr. Crawford’s statement…
Scientific American: Preparing for a Pandemic Wed, 26 Oct 2005 An article in Scientific American (excerpt below) provides a totally different explanation of a pandemic influenza outbreak than that offered in reports sent in yesterday’s Infomail. Two sites have been highly recommended for reliable information: FLU WIKI: http://www.fluwikie.com/ and EFFECT…
An Epidemic of Overreaction /The scare Scenario / The Fear Epidemic Thu, 27 Oct 2005 Dr. Marc Siegel, a practicing internist and an associate professor of medicine at New York University School of Medicine, and a subscriber to the AHRP Infomails, forwarded 3 recent Op Ed articles he has published–in…
NYT reporter Judith Miller: Woman of Mass Destruction–Not Joan of Arc Sat, 22 Oct 2005 New York Times columnist, Maureen Dowd: “Investigative reporting is not stenography.” Judith Miller”s reputation has taken a sprialling spin downward from her own doing–she transcribed what her Administration “sources” and their conmen fed her- Unfortunately,…
States Protest Contributions to Drug Plan – New York Times Tue, 18 Oct 2005 The New York Times reports: “On Monday, the administration unveiled a new online tool to help Medicare beneficiaries choose a prescription plan from the dozens of plans available in each state. But some of the information…
October 14, 2005 link to pdf of original letter Dr. Russell Katz Director, Neuropharmacological Drug Products Food and Drug Administration, FDA 120 1451 Rockville Pike, Room 4037 Rockville, MD 20852 Re: FDA Neurontin Safety Analyses Dear Dr. Katz: Due to the continued public danger facing a substantial class of…
Bush’s Choice for F.D.A. Chief to Keep Other Job Mon, 26 Sep 2005 President Bush proposes to appoint Dr. von Eschenbach to head the FDA while at the same time maintaining his “day job” as head of the National Cancer Institute. Clearly the administration thinks very little about the importance…
Medical Costs: “It’s a broken system. And at some point, it will fall apart" – Conflicts of Interest – NYT Thu, 22 Sep 2005 Medical device manufacturers have taken a leaf from pharmaceutical companies–they too bribe doctors to use their products. The New York Times repors about one such case…
